On their website they're even calling it Phase 2a. So no, highly unlikely. Tinnitus is listed as a secondary outcome measure in the trial design, so yes, they will most likely report on that. Hyperacusis isn't mentioned I believe.Would it still be possible that after Phase 2a they will go to Phase 3?
When do you think they will let us know if it helps with tinnitus and hyperacusis? You reckon at the end of Phase 3 or when the drug gets released?